MAIN ACTIVITIES

At Eumedica AG the focus is on supply continuity, quality, and regulatory compliance.

Our team operates  in order to make sure that  our product range is always managed on time and meet the highest level of exigences.

Supply Chain Management

Our network of suppliers, contract manufacturers, forwarders, logistic providers and internal API manufacturing site is coordinated by an internal team, responsible for the end-to-end operational supply chain and manufacturing of the Eumedica product portfolio. We collaborate with cross functional teams across the company such as Quality, Regulatory Affairs, and Technical Transfer to ensure the continuity of access to lifesaving therapeutic solutions for our patients.

 

Thanks to our highly motivated and skilled specialists with pharmaceutical and scientific background, as well as business trained staff, we ensure Eumedica AG’s shared goal by delivering continuous supply of our high-quality medicines in a cost-efficient way.

Regulatory Affairs

Our Regulatory Affairs department provides professional expertise in complying with regulations from Health Authorities for our full medical product portfolio. Our dedicated team of experienced professionals together with external partners ensures the regulatory compliance throughout the entire lifecycle of our pharmaceutical products in order to guarantee safe, efficient and high-quality medicines to our patients. Various multidisciplinary tasks of our team include, defining and executing regulatory strategies for new submissions, marketing authorisation transfers, technical transfers and updating product informations.

QA

Eumedica's Pharmaceutical Quality System (PQS) allows establishing and maintaining the commercialisation of products with the quality attributes appropriate to meet the needs of patients, health care professionals, regulatory authorities and other internal and external customers.

For our products we ensure compliance to our quality expectations through:

  • Qualification of our CMOs (e.g. audits, quality agreements).

  • Review of batch relevant documentation.

  • Review of deviations, changes, complaints, CAPAs.

  • Release of batches for distribution/to market.

We continuously improve our systems and processes according to current GxP standards to ensure the high quality of our products for the future.

 EUMEDICA Pharmaceuticals AG | info@eumedica.ch | Legal information |Privacy policy |2020|

All rights reserved | EUMEDICA AG, Basel Switzerland

  • LinkedIn